Clinical Trial Update: Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This document reports a phase 2 clinical trial evaluating the combination of apatinib and docetaxel for advanced esophageal squamous cell carcinoma, with the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Advanced Esophageal Squamous Carcinoma | Phase 2 | Status: UNKNOWN